BR0110268A - Inibidores de permutadores sódio-hidrogênio do tipo 1(nhe-1) - Google Patents

Inibidores de permutadores sódio-hidrogênio do tipo 1(nhe-1)

Info

Publication number
BR0110268A
BR0110268A BR0110268-0A BR0110268A BR0110268A BR 0110268 A BR0110268 A BR 0110268A BR 0110268 A BR0110268 A BR 0110268A BR 0110268 A BR0110268 A BR 0110268A
Authority
BR
Brazil
Prior art keywords
nhe
type
sodium hydrogen
inhibitor
inhibitors
Prior art date
Application number
BR0110268-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Weichao George Chen
Eric David Cox
Angel Guzman-Perez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0110268A publication Critical patent/BR0110268A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0110268-0A 2000-04-28 2001-02-28 Inibidores de permutadores sódio-hidrogênio do tipo 1(nhe-1) BR0110268A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
BR0110268A true BR0110268A (pt) 2003-12-30

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110268-0A BR0110268A (pt) 2000-04-28 2001-02-28 Inibidores de permutadores sódio-hidrogênio do tipo 1(nhe-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (cs)
JP (1) JP2003531900A (cs)
KR (1) KR20020093079A (cs)
CN (1) CN1225466C (cs)
AP (1) AP2002002651A0 (cs)
AR (1) AR028375A1 (cs)
AU (1) AU2001235896A1 (cs)
BG (1) BG107139A (cs)
BR (1) BR0110268A (cs)
CA (1) CA2407535A1 (cs)
CO (1) CO5221125A1 (cs)
CR (1) CR6797A (cs)
CZ (1) CZ20023408A3 (cs)
DZ (1) DZ3310A1 (cs)
EA (1) EA004882B1 (cs)
EE (1) EE200200615A (cs)
GT (1) GT200100064A (cs)
HN (1) HN2001000042A (cs)
HR (1) HRP20020851A2 (cs)
HU (1) HUP0300651A2 (cs)
IL (1) IL152075A0 (cs)
IS (2) IS6567A (cs)
MA (1) MA26897A1 (cs)
MX (1) MXPA02010600A (cs)
MY (1) MY133842A (cs)
NO (1) NO20025132L (cs)
NZ (1) NZ521348A (cs)
OA (1) OA12256A (cs)
PA (1) PA8513301A1 (cs)
PE (1) PE20011270A1 (cs)
PL (1) PL357765A1 (cs)
SK (1) SK14872002A3 (cs)
SV (1) SV2002000418A (cs)
TN (1) TNSN01065A1 (cs)
TR (1) TR200202439T2 (cs)
UA (1) UA73348C2 (cs)
UY (1) UY26680A1 (cs)
WO (1) WO2001083470A1 (cs)
YU (1) YU79602A (cs)
ZA (1) ZA200208605B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (ja) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク ナトリウム−水素交換輸送体1型阻害剤のエタノラート
EP1456181A1 (en) * 2001-12-19 2004-09-15 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
MXPA04008646A (es) * 2002-05-02 2004-12-06 Pfizer Prod Inc Tratamiento para la diabetes y complicaciones diabeticas con inhibidores del nhe-1.
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EE200200615A (et) 2004-04-15
WO2001083470A1 (en) 2001-11-08
UA73348C2 (en) 2005-07-15
HN2001000042A (es) 2001-07-09
HUP0300651A2 (hu) 2003-07-28
HRP20020851A2 (en) 2005-02-28
JP2003531900A (ja) 2003-10-28
IL152075A0 (en) 2003-05-29
UY26680A1 (es) 2001-12-28
TR200202439T2 (tr) 2003-02-21
SV2002000418A (es) 2002-07-03
SK14872002A3 (sk) 2004-03-02
AR028375A1 (es) 2003-05-07
CN1225466C (zh) 2005-11-02
OA12256A (en) 2003-11-06
CA2407535A1 (en) 2001-11-08
MA26897A1 (fr) 2004-12-20
PA8513301A1 (es) 2003-09-05
EA200201023A1 (ru) 2003-02-27
CO5221125A1 (es) 2002-11-28
PE20011270A1 (es) 2001-12-12
GT200100064A (es) 2002-03-22
CR6797A (es) 2004-05-17
BG107139A (bg) 2003-07-31
NO20025132D0 (no) 2002-10-25
AU2001235896A1 (en) 2001-11-12
IS6567A (is) 2002-09-24
EP1276737A1 (en) 2003-01-22
EA004882B1 (ru) 2004-08-26
PL357765A1 (en) 2004-07-26
KR20020093079A (ko) 2002-12-12
ZA200208605B (en) 2003-10-24
MXPA02010600A (es) 2003-03-10
YU79602A (en) 2006-05-25
DZ3310A1 (fr) 2001-11-07
IS6588A (is) 2002-10-21
AP2002002651A0 (en) 2002-12-31
CZ20023408A3 (cs) 2004-01-14
NO20025132L (no) 2002-12-12
NZ521348A (en) 2004-09-24
TNSN01065A1 (fr) 2005-11-10
MY133842A (en) 2007-11-30
CN1426404A (zh) 2003-06-25

Similar Documents

Publication Publication Date Title
BR0110101A (pt) N-acil-sulfonamidas promotoras de apoptose
BR0311132A (pt) Inibidores do vìrus da hepatite c
SI1109787T1 (sl) Arilpiperazini in njihova uporaba kot metaloproteinazo inhibirajoca sredstva (MMP)
DK1001930T3 (da) N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser
BR0208105A (pt) Inibidores de metaloproteinase
YU44398A (sh) Derivati supstituisanog benzensulfonamida kao prolekovi cox-2 inhibitora
BR0010166A (pt) Composto modulador de ace-2, composto inibidor de ace-2, métodos para o tratamento de um estado associado a ace-2 em um paciente e para inibir a hidrólise de um peptìdeo de marcação de ace-2, e, composição farmacêutica
NO971537D0 (no) Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer for metalloproteaser
PA8521701A1 (es) Derivados de pirazol
BR0109542A (pt) Derivados de imidazopirina alquilados
BR0110268A (pt) Inibidores de permutadores sódio-hidrogênio do tipo 1(nhe-1)
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
CO5150165A1 (es) Inhibidores de proteasa: tipo catepsina k
BR0112028A (pt) Inibidores de farnesil transferase
BR0115616A (pt) Preparação de inibidores de permutadores sódio-hidrogênio do tipo 1
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
CO5160328A1 (es) Derivados de etan sulfonil-piperidina
BR0015275A (pt) Cristais de inibidores de permutadores sódio-hidrogênio do tipo 1
BR0007278A (pt) Inibidores de hidroxamato reverso demetalo-proteinases de matriz
UY26664A1 (es) Hidrazidas y alcoxiamidas inhibidoras de la angiogénesis.
BR0005122A (pt) Método para a preparação de inibidor de permutador de sódio-hidrogênio do tipo 1
WO2004006927A3 (en) Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
BR0116412A (pt) Inibidores de pró-colagénio c-proteinase
ECSP003742A (es) Cristales de inhibidor del intercambiador de sodio-hidrogeno tipo i
UY26417A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrógeno tipo 1

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.